Stay updated on IRX-2 Regimen in Women With Cervical/ Vulvar Neoplasia 3 Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen in Women With Cervical/ Vulvar Neoplasia 3 Clinical Trial page.

Latest updates to the IRX-2 Regimen in Women With Cervical/ Vulvar Neoplasia 3 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the study record versions, and removed the 'HHS Vulnerability Disclosure' link along with the earlier 'Revision: v3.3.2' entry.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRecord history shows a new revision entry (v3.3.2) and removal of a prior revision (v3.2.0); these are version-tracking updates to the study record and do not change the study data or key details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding lapse banner was removed from the page, a non-substantive UI element; core study record content and version history are unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check60 days agoChange DetectedA new version entry on 2025-03-26 adds updates to recruitment status and related study status details in the history.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

- Check96 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to IRX-2 Regimen in Women With Cervical/ Vulvar Neoplasia 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen in Women With Cervical/ Vulvar Neoplasia 3 Clinical Trial page.